Solar Keratosis

Introduction

Solar keratosis, also known as actinic keratosis (AK), is a premalignant skin lesion caused by chronic sun exposure. It appears as a rough, scaly, erythematous patch on sun-exposed areas such as the face, scalp, ears, and hands.

Although benign, 5–10% of cases progress to squamous cell carcinoma (SCC) if left untreated. Early detection and treatment are crucial to prevent malignant transformation.

Epidemiology and Risk Factors

Prevalence:

  • Common in fair-skinned individuals (Fitzpatrick skin types I & II).
  • Affects 40–60% of Australians over 40 years old (high UV exposure).
  • More frequent in outdoor workers, farmers, surfers, and athletes.

Risk Factors:

  • Chronic sun exposure (UV radiation) (primary cause).
  • Older age (>50 years) – Cumulative UV damage over time.
  • Fair skin, light hair, blue eyes (low melanin protection).
  • Immunosuppression (HIV, post-organ transplant patients on immunosuppressants).
  • History of previous AKs or non-melanoma skin cancers.
  • Smoking and environmental pollutants (minor contributing factors).

Pathophysiology

  1. UV-Induced DNA Damage:
    • UV radiation causes mutations in keratinocytes, particularly in the p53 tumor suppressor gene.
    • Leads to dysregulated cell growth and abnormal keratinocyte proliferation.
  2. Chronic Inflammation & Dysplasia:
    • Persistent UV exposure triggers chronic inflammation, increasing the risk of malignant transformation.
    • Dysplastic keratinocytes accumulate in the epidermis, forming scaly, rough lesions.
  3. Progression to Squamous Cell Carcinoma (SCC):
    • Some AKs persist and enlarge, developing invasive SCC.
    • Thin AKs are less likely to transform, while thicker, ulcerated AKs have a higher risk.

Clinical Features

  1. Characteristic Skin Changes
  • Rough, scaly, sandpaper-like texture.
  • Poorly defined borders, pink, red, or flesh-colored lesion.
  • Can be flat or slightly raised, often <1 cm in diameter.
  • Commonly found on sun-exposed areas:
    • Face, scalp (in bald individuals), ears, dorsum of hands, forearms, shoulders, lower legs.
  1. Variants of Actinic Keratosis
Variant Key Features
Hypertrophic AK Thicker, hyperkeratotic, warty-like lesion, may mimic SCC
Pigmented AK Brown, may resemble lentigo maligna (early melanoma)
Atrophic AK Flat, thin, red patch, lacking significant scaling
Bowenoid AK Atypical, severe dysplasia, high risk of SCC
Actinic Cheilitis AK affecting lip vermilion, common in older men
  1. Symptoms
  • Usually asymptomatic but may cause:
    • Tenderness, itching, burning sensation.
    • Bleeding, ulceration (if progressing to SCC).

Diagnosis

  1. Clinical Diagnosis (Most Cases)
  • History of chronic sun exposure.
  • Characteristic rough, scaly patches on sun-exposed areas.
  1. Dermoscopy (For Atypical Cases)
  • White or yellow scale with an erythematous background.
  • Dilated blood vessels (telangiectasia).
  • Follicular plugs.
  1. Biopsy (If Concern for SCC or Atypical Features)
  • Indications for biopsy:
    • >1 cm lesion, rapidly growing, ulcerated, or thickened.
    • Failed response to treatment.
    • Suspicion of squamous cell carcinoma.
  • Histopathology Findings:
    • Atypical keratinocytes with nuclear pleomorphism.
    • Dysplasia confined to the basal layer (vs. SCC, where full-thickness dysplasia is seen).
  1. Differential Diagnosis
Condition Key Differences
Seborrheic keratosis Waxy, “stuck-on” appearance, no sun exposure link
Squamous cell carcinoma (SCC) Ulceration, rapid growth, bleeding, firm nodular lesion
Lichenoid keratosis Small, pinkish papule, no sun exposure association
Lentigo maligna (early melanoma) Uniform brown pigment, slow-growing

Management and Treatment

  1. General Measures
  • Sun protection (SPF ≥50 sunscreen, wide-brim hats, protective clothing).
  • Routine skin checks (especially for high-risk individuals).
  • Patient education on early warning signs of malignancy.
  1. First-Line Treatments (For Isolated or Small Lesions)
  • Cryotherapy (Liquid Nitrogen) (Most Common Treatment)
    • Destroys abnormal keratinocytes via freezing (-196°C).
    • Effective for thin AKs, but may cause temporary hypopigmentation.
    • Healing takes ~10–14 days.
  • Curettage & Electrodessication
    • Scraping followed by cauterization of the base.
    • Used for thicker or hypertrophic AKs.
  • Shave Excision (For Large, Persistent Lesions)
    • Provides histological confirmation.
    • Used when SCC is suspected.
  1. Field Therapy (For Multiple or Widespread Lesions)
  • 5-Fluorouracil (5-FU) Cream (Efudix 5%)
    • First-line topical therapy for multiple AKs.
    • Causes redness, crusting, erosion before healing.
    • Apply for 2–4 weeks.
  • Imiquimod (Aldara 5%)
    • Immune-modulating agent that stimulates T-cell response.
    • Used for multiple or facial AKs.
    • Apply 3 times weekly for 4–6 weeks.
  • Diclofenac 3% Gel (Solaraze) + Hyaluronic Acid
    • Anti-inflammatory action, well-tolerated but slower response.
    • Used for mild AKs over 3 months.
  • Ingenol Mebutate (Picato)
    • Rapid effect (only 3-day application needed).
    • Causes local skin irritation, redness, and scabbing.
  • Photodynamic Therapy (PDT) (For Large Areas or Resistant AKs)
    • Topical photosensitizer (e.g., Methyl aminolevulinate) + Red light exposure.
    • Highly effective but may cause pain and peeling.

Complications

  • Progression to Squamous Cell Carcinoma (SCC) (~5–10% of AKs transform over time).
  • Persistent irritation, tenderness, and discomfort.
  • Scarring or post-inflammatory pigment changes after treatment.

Prevention Strategies

  1. Daily broad-spectrum sunscreen (SPF 50+).
  2. Avoid peak UV exposure (10 AM–4 PM).
  3. Regular dermatologic skin checks (especially in high-risk individuals).
  4. Use of protective clothing (hats, long sleeves, UV-blocking sunglasses).

Prognosis and Follow-Up

  • Early treatment prevents SCC transformation.
  • Regular follow-up every 6–12 months for high-risk patients.
  • Good response to topical and procedural therapies if started early.

Conclusion

Solar keratosis (actinic keratosis) is a precancerous lesion caused by chronic sun exposure. While benign, some cases progress to squamous cell carcinoma, necessitating early treatment and sun protection. Cryotherapy, topical therapies (5-FU, Imiquimod), and photodynamic therapy are effective options. Prevention via sun protection and routine skin checks is key to reducing long-term skin cancer risk.

 

Previous Topic
Back to Lesson
Next Lesson